QSAR study of imidazoline antihypertensive drugs

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 15, 2008, Pages 7134-7140

  Nikolic, Katarina ^a   Filipic, Slavica ^a   Agbaba, Danica ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Centrally acting antihypertensives; I1 R ligands; I1 receptor; Pharmacophore; Structure activity relationship

Indexed keywords

4 CHLORO 2 (2 IMIDAZOLIN 2 YLAMINO)ISOINDOLINE; 4 LODOCLONIDINE; ALPHA 2 ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; CIRAZOLINE; CLONIDINE; EFAROXANE; GUANABENZ; GUANFACINE; IDAZOXANE; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; LNP 906; MOXONIDINE; NAPHAZOLINE; OXYMETAZOLINE; PHENTOLAMINE; RILMENIDINE; TIZANIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DENSITY FUNCTIONAL THEORY; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; LINEAR REGRESSION ANALYSIS; MULTIPLE LINEAR REGRESSION ANALYSIS; NONHUMAN; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL SIGNIFICANCE; THROMBOCYTE; VALIDATION STUDY;

EID: 84962448550     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.06.051     Document Type: Article

References (38)

1. Head G.A., and Burke S.L. J. Hypertens. 18 9 (2000) 1263-1276
2. Ernsberger P. J. Cardiovasc. Pharmacol. 35 (2000) S27-S41
3. Bousquet P., and Feldman J. Drugs 58 (1999) 799-812
4. Bock C., Niederhoffer N., and Szabo B. Naunyn. Schmiedebergs Arch Pharmacol. 359 (1999) 262-271
5. Head G.A., and Mayorov D.N. Cardiovasc. Hematol. Agents 4 1 (2006) 17-32
6. Heemskerk F.M.J., Dontenwill M., Greney H., Vonthron C., and Bousquet P. J. Neurochem. 71 (1998) 2193-2202
7. Piletz J.E., and Sletten K. J. Pharmacol. Exp. Ther. 267 (1993) 1493-1502
8. Ernsberger P., Graves M.E., Graff L.M., Zakieh N., Nguyen P., and Collins L.A. Ann. N.Y. Acad. Sci. 763 (1995) 22-42
9. Separovic D., Kester M., and Ernsberger P. Mol. Pharmacol. 49 (1996) 668-675
10. Greney H., Ronde P., Magnier C., Maranca F., Rascente C., Quaglia W., Giannella M., Pigini M., Brasili L., Lugnier C., Bousquet P., and Dontenwill M. Mol. Pharm. 57 (2000) 1142-1151
11. Piletz J.E., Ivanov T.R., Sharp J.D., et al. DNA Cell Biol. 19 (2000) 319-329
12. Piletz J.E., Deleersnijder W., Roth B.L., Ernsberger P., Zhu H., and Ziegler D. Ann. N.Y. Acad. Sci. 1009 (2003) 419-426
13. Lim K.P., and Hong W. J. Biol. Chem. 279 (2004) 54770-54782
14. Alahari S.K., and Nasrallah H. J. Biochem. 377 (2004) 449-457
15. Remko M., Walshb O.A., and Richardsb W.G. Phys. Chem. Chem. Phys. 3 (2001) 901-907
16. Remko M., Van Duijnen P.Th., and Swart M. Struct. Chem. 14 (2003) 271
17. Remko M., Swart M., and Bickelhaupt M. Bioorg. Med. Chem. 14 (2006) 1715-1728
18. Byre G., Mostad A., and Rømming Ch. Acta Chem. Scand. B30 (1976) 843
19. Hu H.J., Sun C.R., Zhang H., and Pan Y.J. Acta Cryst. E61 (2005) o413-o415
20. Piletz J.E., Zhu H., and Chikkala D.N. J. Pharmacol. Exp. Ther. 279 (1996) 694-702
21. Marvin 4.0.5, ChemAxon, Budapest, Hungary. www.chemaxon.com/products.html.
22. Becke D. J. Chem. Phys. 98 (1993) 5648
23. Lee C., Yang W., and Parr R.G. Phys. Rev. B 37 (1988) 785
24. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Zakrzewski V.G., Montgomery Jr. J.A., Stratmann R.E., Burant J.C., Dapprich S., Millam J.M., Daniels A.D., Kudin K.N., Strain M.C., Farkas O., Tomasi J., Barone V., Cossi M., Cammi R., Mennucci B., Pomelli C., Adamo C., Clifford S., Ochterski J., Petersson G.A., Ayala P.Y., Cui Q., Morokuma K., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Cioslowski J., Ortiz J.V., Baboul A.G., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Gomperts R., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Gonzalez C., Challacombe M., Gill P.M.W., Johnson B.G., Chen W., Wong M.W., Andres J.L., Head-Gordon M., Replogle E.S., and Pople J.A. Gaussian 98 (Revision A.7) (1998), Gaussian, Inc., Pittsburgh PA
25. Miertus S., Scrocco E., and Tomasi J. Chem. Phys. 55 (1981) 117
26. Cammi R., and Tomasi J. J. Comput. Chem. 16 (1995) 1449
27. CS Chem3D Ultra 7.0 (Property Picker ActiveX Control), Cambridge Soft Corporation, 100 Cambridge Park Dr. Cambridge, MA 02140-2317 U.S.A. http://www.cambridgesoft.com/.
28. Casewit C.J., Colwell K.S., and Rappe A.K. J. Am. Chem. Soc. 114 (1992) 10035-10046
29. ArgusLab 4.0, Mark A. Thompson, Planaria Software LLC, Seattle, http://www.ArgusLab.com.
30. Zheng S., Chang C.H., and Ernsberger P. J. Neurochem. 101 (2007) 99-108
31. XNUMBERS, Ver.4.7, March 2006, Multi Precision Floating Point Computing and Numerical Methods for EXCEL/2000 XP.
32. Allen D.M. Technometrics 16 (1974) 125
33. Greney H., Urosevic D., Schann S., Dupuy L., Bruban V., Ehrhardt J.-D., Bousquet P., and Dontenwill M. Mol. Pharmacol. 62 (2002) 181-191
34. Urosevic D., Schann S., Ehrhardt J.-D., Bousquet P., and Greney H. Br. J. Pharmacol. 142 (2004) 609-617
35. Schann S., Bruban V., Pompermayer K., Feldman J., Pfeiffer B., Renard P., Scalbert E., Bousquet P., and Ehrhardt J.-D. J. Med. Chem. 44 (2001) 1588-1593
36. Gupta M.K., Mishra P., Prathipati P., and Saxena A.K. Bioorg. Med. Chem. 10 (2002) 3713-3716
37. Joy S., Nair P.S., Hariharan R., and Pillai M.R. In Silico Biol. 6 (2006) 0053
38. Jones G., Willett P., Glen R.C., Leach A.R., and Taylor R. J. Mol. Biol. 267 (1997) 727-748